Evaluation of the Patient's Risk Profile Using the Peri-implantitis Risk Diagram
Launched by BERCESTE GULER · Nov 8, 2022
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
Nowadays, dental implants are increasingly applied worldwide for the restoration of lost teeth. It is known that the survival rates of dental implant treatments are quite high, but in recent studies, the maintenance of the health of the peri-implant tissues and the satisfaction of the patient play a more important role in the success of the dental implant, not the survival. Various risk factors defined in the literature should be eliminated in order for the patient to be able to use implant-supported prostheses for a longer period of time. In the literature, a Spider Web scheme named "Perio...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be over 18
- • The condition of making dental implants in Kütahya Health Sciences University, Faculty of Dentistry, Department of Periodontology
- • Finding radiographic documentation of dental implants
- • Functioning of the implants in the mouth for at least 1 year
- Exclusion Criteria:
- • Antibiotic use in the 3 months before the first examination
- • Patients who have not received regular implant maintenance therapy
- • Pregnant and breastfeeding women
- • Mentally retarded patients
About Berceste Guler
Berceste Guler is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a focus on collaboration and integrity, Berceste Guler fosters partnerships with research institutions and healthcare professionals to facilitate the development of cutting-edge therapies. The organization emphasizes ethical considerations and regulatory compliance, ensuring that all trials prioritize participant safety and data integrity. Through its comprehensive approach to clinical trial management, Berceste Guler aims to contribute significantly to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kütahya, , Turkey
Patients applied
Trial Officials
Berceste Güler
Principal Investigator
Kütahya Health Sciences University Faculty of Dentistry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials